Medical News Today: Bosutinib is well-suited for older patients with chronic myeloid leukemia

In our final report from the 20th Congress of the European Hematology Association, we look at the results of a clinical trial for the tyrosine kinase inhibitor bosutinib.

Source: Health News from Medical News Today - July 4, 2015 Category: Consumer Health News Tags: Lymphoma / Leukemia / Myeloma Source Type: news